Stock Report

All about this stock under one free report Last Updated: 07-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Arbutus Biopharma Corp (ABUS) Key Ratios

Stock Card factsheet share-fund-plan-icon

$5.15

up-down-arrow $0.03 (0.59%)

As on 04-Sep-2026 16:09EDT

Market cap

info icon

$1,020 Mln

Revenue (TTM)

info icon

$182 Mln

P/E Ratio

info icon

6.5

P/B Ratio

info icon

3.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -99.43 -90.56 1,078.78 97.65 85.15
EBIT -103.02 -300.90 367.23 60.73 33.71
Net Profit -103.03 -303.84 382.12 60.03 32.85
EPS -103.00 -298.61 374.07 54.58 24.46
Book Value -- -- -22.02 -23.31 -18.20
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -589.02-519.4384.27-237.19-1,130.82
Net Margin info ---427.1584.23----
Return on equity info -55.76-53.7691.29-38.52-68.76
Return on Capital info -51.87-49.10---36.37-64.08
Return on Assets info -41.04-40.5079.37-29.60-50.65
Debt to Equity (x) info ----0.000.050.06

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
--
-36.37
-64.08
-55.16
-41.13
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

91.29

Higher than Peers by 92.11

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
91.29
-38.52
-68.76
-59.99
-45.35
Peer Median
-0.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

79.37

Higher than Peers by 82.93

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
79.37
-29.60
-50.65
-42.88
-34.74
Peer Median
-3.57
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

84.27

Higher than Peers by 116.55

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
84.27
-237.19
-1,130.82
-399.04
-162.19
Peer Median
-32.28
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

84.23

Higher than Peers by 94.34

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
84.23
-237.88
-1,133.04
-401.57
-168.63
Peer Median
-10.12
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

1,078.78

Higher than Peers by 1,068.69

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
1,078.78
1.28
-0.66
-0.54
2.55
Peer Median
10.08
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

367.23

Higher than Peers by 339.31

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
367.23
52.13
3.60
-14.39
13.77
Peer Median
27.92
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

382.12

Higher than Peers by 320.85

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
382.12
52.09
4.02
-4.89
8.91
Peer Median
61.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

374.07

Higher than Peers by 301.33

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
374.07
0.52
0.15
0.04
0.40
Peer Median
72.74
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

203.81

Higher than Peers by 211.28

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
203.81
--
--
--
--
Peer Median
-7.47
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
--
0.05
0.06
0.08
0.09
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.00

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
0.00
0.01
0.00
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

81.42

Higher than Peers by 74.86

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
81.42
15.73
8.15
5.87
4.60
Peer Median
6.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

81.42

Higher than Peers by 74.58

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
81.42
--
--
5.95
4.69
Peer Median
6.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

2,014.87

Higher than Peers by 2,013.97

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
2,014.87
-344.37
-509.36
-157.71
-36.67
Peer Median
0.89
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

98.91

Higher than Peers by 76.65

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
98.91
12.41
39.04
9.79
3.46
Peer Median
22.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.94

Higher than Peers by 0.79

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
0.94
0.12
0.04
0.11
0.20
Peer Median
0.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
--
53.89
123.85
31.49
10.54
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
--
--
-470.06
-11.52
-936.67
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
--
1,755.31
733.01
16.71
856.69
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
--
--
-1,079.22
3.26
-1,782.82
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

6.52

Lower than Peers by 10.64

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
6.52
-27.51
-8.88
-5.78
-5.18
Peer Median
17.16
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

3.92

No difference

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
3.92
12.04
6.38
3.97
2.63
Peer Median
3.92
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

6.01

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
6.01
-25.25
-7.38
-4.28
-3.64
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

1,020

Higher than Peers by 900

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arbutus Biopharma Corp (ABUS)
1,020
--
--
--
--
Peer Median
120
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...